TITLE

Clinical response to unintentionally rapid infusion of drotrecogin alfa (activated)

AUTHOR(S)
Urban, Theresa M.; Mitchell, George A.; Wellborn-Kim, Jennifer J.; Terneus Jr., William F.; Callahan, Charles M.; Mendes, Joseph; Webber, Shannon L.
PUB. DATE
July 2010
SOURCE
American Journal of Health-System Pharmacy;7/15/2010, Vol. 67 Issue 14, p1174
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Purpose. The case of a patient with severe sepsis who received a bolus dose of 184 μg/ kg of drotrecogin alfa (activated) over one hour is reported. Summary. An 84-year-old woman who had undergone right total knee replacement was admitted to the hospital from a rehabilitation facility with an initial diagnosis of mental status changes and a suspected urinary tract infection. Examination of the patient's incision from her recent knee surgery revealed a discharge, and a culture was obtained. The patient was diagnosed with sepsis, intubated, and transferred to the intensive care unit. Multiple antibiotics were administered, but the patient's condition continued to deteriorate. In addition, the patient developed acute renal failure, required a ventilator, had cyanotic limbs, and had partially compensated metabolic acidosis. On hospital day 7, drotrecogin alfa (activated) was initiated. She inadvertently received an infusion of 184 μg/kg of drotrecogin alfa over 1 hour. Nine hours later, she received drotrecogin alfa 24 μg/kg/hr for 95 hours. The patient's clinical status was improved after the initial infusion. Peripheral limb cyanosis was markedly decreased, with pink, warm extremities. In addition, the patient's clinical laboratory test values improved after administration of drotrecogin alfa. However, the patient was unable to recover fully from the acute kidney failure and was discharged to hospice care. Conclusion. A drotrecogin alfa dose of 184 μg/kg i.v. was erroneously administered over 1 hour to a patient with sepsis. Nine hours later, a drotrecogin alfa infusion of 24 μg/kg/hr was started and continued for 95 hours. The patient improved clinically and had no apparent adverse events.
ACCESSION #
51870280

 

Related Articles

  • Outpatient parenteral antimicrobial therapy. Kayley, Jill // British Journal of Nursing (BJN);2/1/2012 Supplement, Vol. 21 Issue 2, pS3 

    The article discusses various reports which are published within the issue, including one by Gail Sansivero on vascular access devices, one by Janice Gabriel on how the human venous system is affected by the aging process and one by Donnellan et al. on antimicrobial haemostatic intravenous dressing.

  • Frequency of the Central Venous Catheter Colonization in Surgical Intensive Care Unit. Hodzic, Samir; Tihic, Nijaz; Smajid, Jasmina; Omerbegovic, Muhamed; Sljivic, Mirsad // Medicinski Arhiv;2010, Vol. 64 Issue 4, p245 

    The use of central venous catheters (CVC) carries a risk from local and systemic infectious complications, with prevalence of 6% in patients in Intensive care unit. Microorganisms colonizing the CVC originate from patient's or staff member's skin, but the source can a contaminated infusion...

  • Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Leuthner, Kimberly D.; Buechler, Kristin A.; Kogan, David; Saguros, Agafe; Lee, H. Stephen // Therapeutics & Clinical Risk Management;Jun2016, Vol. 12, p931 

    Acute bacterial skin and skin structure infections (ABSSSI) are a common disease causing patients to seek treatment through the health care system. With the continued increase of drug-resistant bacterial pathogens, these infections are becoming more difficult to successfully cure....

  • Drotrecogin alfa in tropical infections and refractory multi-organ failure. Kapadia, Farhad; Shirwadkar, Charudatt // Intensive Care Medicine;Aug2006, Vol. 32 Issue 8, p1281 

    A letter to the editor is presented about the therapeutic effect of drotrecogin alfa in patients suffering from malaria and leptospirosis with refractory multi-organ failure.

  • Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. Christ, Frauke; Voet, Arnout; Marchand, Arnaud; Nicolet, Stefan; Desimmie, Belete A.; Marchand, Damien; Bardiot, Dorothée; Van der Veken, Nam Joo; Van Remoortel, Barbara; Strelkov, Sergei V; De Maeyer, Marc; Chaltin, Patrick; Debyser, Zeger // Nature Chemical Biology;Jun2010, Vol. 6 Issue 6, p442 

    Lens epithelium–derived growth factor (LEDGF/p75) is a cellular cofactor of HIV-1 integrase that promotes viral integration by tethering the preintegration complex to the chromatin. By virtue of its crucial role in the early steps of HIV replication, the interaction between LEDGF/p75 and...

  • Pharmacokinetic, Pharmaco-dynamic, and Clinical Efficacy of Continuous or Extended Infusion Regimens of Piperacillin/Tazobactam. Song, Jessica C. // Infectious Disease Alert;Jun2010, Vol. 29 Issue 9, p98 

    The article discusses pharmacokinetics, pharmacodynamics and clinical efficacy of infusion regimens of piperacillin/tazobactam (P/T). It mentions that P/T provides one of the broadest antimicrobial spectrums with an effective mechanism for maintaining potency amid the presence of...

  • Supportive care.  // Annals of Oncology;Oct2010 Supplement 8, Vol. 21 Issue suppl_8, pviii376 

    No abstract available.

  • MARKERI GENITALI AI INFECÅ¢IEI CU CHLAMYDIA TRACHOMATIS LA FEMEI CU BOALÄ‚ INFLAMATORIE PELVINÄ‚. Dragodan, A. V.; Manolescu, L.; Câmpean, D. // Romanian Journal of Infectious Diseases;2012, Vol. 15 Issue 1, p23 

    Chlamydia trachomatis, one of the most common bacteria sexually transmitted, with over 90 million new cases annually/WHO, is a major etiologic agents of PID (pelvic inflammatory disease), being detected in approximately 20-40% of cases in the cervix of women with this condition. The objective of...

  • The Influence of Anti-Infective Periodontal Treatment on C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Demmer, Ryan T.; Trinquart, Ludovic; Zuk, Aleksandra; Fu, Benjamin C.; Blomkvist, Josefin; Michalowicz, Bryan S.; Ravaud, Philippe; Desvarieux, Moïse // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background:Periodontal infections are hypothesized to increase the risk of adverse systemic outcomes through inflammatory mechanisms. The magnitude of effect, if any, of anti-infective periodontal treatment on systemic inflammation is unknown, as are the patient populations most likely to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics